Free Trial

Harmony Biosciences (HRMY) SEC Filings & 10K Form

Harmony Biosciences logo
$34.19 0.00 (0.00%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$34.18 0.00 (-0.01%)
As of 08/8/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Harmony Biosciences SEC Filings

DateFilerForm TypeView
08/05/2025
7:00 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2025
7:16 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/11/2025
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
7:15 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
7:00 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
1:47 PM
BlackRock, Inc. (Filed by)
Harmony Biosciences (Subject)
Form SCHEDULE 13G/A
04/04/2025
4:51 PM
Harmony Biosciences (Issuer)
Philip Ron M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/04/2025
4:52 PM
Harmony Biosciences (Issuer)
Philip Ron M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
3:17 PM
Harmony Biosciences (Filer)
Form DEF 14A
04/04/2025
3:19 PM
Harmony Biosciences (Filer)
Form DEFA14A
04/04/2025
3:20 PM
Harmony Biosciences (Filer)
Form ARS
04/03/2025
7:15 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
3:27 PM
Harmony Biosciences (Subject)
Kapadia Sandip (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/24/2025
7:15 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
7:00 AM
Harmony Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
5:10 PM
Harmony Biosciences (Subject)
Valor IV Pharma Holdings, LLC (Filed by)
Form SCHEDULE 13G/A
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Harmony Biosciences (Subject)
Form SCHEDULE 13G/A
01/30/2025
8:57 PM
Harmony Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/28/2025
11:51 AM
Harmony Biosciences (Issuer)
Serafin Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:27 PM
Harmony Biosciences (Subject)
Kapadia Sandip (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
3:27 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
3:18 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2025
3:17 PM
Dayno Jeffrey M. (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:15 PM
Harmony Biosciences (Issuer)
Kapadia Sandip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
7:44 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:20 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
3:21 PM
Dayno Jeffrey M. (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
3:21 PM
Harmony Biosciences (Subject)
Kapadia Sandip (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
3:30 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:30 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:26 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
7:15 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:48 PM
Gracias Antonio J. (Reporting)
Harmony Biosciences (Issuer)
Sabater Juan A. (Reporting)
Valor Equity Associates IV L.P. (Reporting)
Valor Equity Capital IV LLC (Reporting)
VALOR EQUITY PARTNERS IV L.P. (Reporting)
VALOR EQUITY PARTNERS IV-A L.P. (Reporting)
VALOR EQUITY PARTNERS IV-B L.P. (Reporting)
Valor IV Pharma Holdings, LLC (Reporting)
Valor Management L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:05 PM
Harmony Biosciences (Issuer)
Marshman Fund Trust II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:06 PM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
3:39 PM
Harmony Biosciences (Filer)
Form 424B7
10/31/2024
3:45 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
4:27 PM
Harmony Biosciences (Filer)
Form 424B7
10/29/2024
3:22 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump set to Boost Social Security Checks by 400%? (Ad)

If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...

Click here to see the details because the stakes couldn't be any higher.
10/29/2024
7:00 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
6:50 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:32 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2024
3:35 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2024
7:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:28 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HRMY) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners